and the blood–brain barrier: the breakthrough Free

Abstract

granulomatous encephalitis is a rare disease that almost always proves fatal. Death occurs mainly due to neurological complications; however, the pathogenesis and pathophysiology associated with this disease remain incompletely understood. Haematogenous spread is a key step in the development of encephalitis, but it is not clear how circulating amoebae breakthrough the blood–brain barrier to gain entry into the central nervous system to produce the disease. This review of the literature describes the parasite factors and immune-mediated mechanisms involved in the blood–brain barrier dysfunction leading to neuropathogenesis.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.2008/000976-0
2008-09-01
2024-03-28
Loading full text...

Full text loading...

/deliver/fulltext/jmm/57/9/1051.html?itemId=/content/journal/jmm/10.1099/jmm.0.2008/000976-0&mimeType=html&fmt=ahah

References

  1. Alsam S., Kim K. S., Stins M., Rivas A. O., Sissons J., Khan N. A. 2003; Acanthamoeba interactions with human brain microvascular endothelial cells. Microb Pathog 35:235–241 [CrossRef]
    [Google Scholar]
  2. Alsam S., Sissons J., Dudley R., Khan N. A. 2005a; Mechanisms associated with Acanthamoeba castellanii (T4) phagocytosis. Parasitol Res 96:402–409 [CrossRef]
    [Google Scholar]
  3. Alsam S., Sissons J., Jayasekera S., Khan N. A. 2005b; Extracellular proteases of Acanthamoeba castellanii (encephalitis isolate belonging to T1 genotype) contribute to increased permeability in an in vitro model of the human blood–brain barrier. J Infect 51:150–156 [CrossRef]
    [Google Scholar]
  4. Benedetto N., Auriault C. 2002a; Prolactin-cytokine network in defence against Acanthamoeba castellanii in murine microglia. Eur Cytokine Netw 13:447–455
    [Google Scholar]
  5. Benedetto N., Auriault C. 2002b; Complex network of cytokines activating murine microglial cell activity against Acanthamoeba castellanii . Eur Cytokine Netw 13:351–357
    [Google Scholar]
  6. Benedetto N., Rossano F., Gorga F., Folgore A., Rao M., Carratelli C. R. 2003; Defense mechanisms of IFN- γ and LPS-primed murine microglia against Acanthamoeba castellanii infection. Int Immunopharmacol 3:825–834 [CrossRef]
    [Google Scholar]
  7. Cerva L. 1967; Intranasal, intrapulmonary and intracardial inoculation of experimental animals with Hartmanella castellanii . Folia Parasitol (Praha 14:207–215
    [Google Scholar]
  8. Culbertson C. G., Smith J. W., Cohen H. K., Minner J. R. 1959; Experimental infection of mice and monkeys by Acanthamoeba . Am J Pathol 35:185–197
    [Google Scholar]
  9. Garate M., Cao Z., Bateman E., Panjwani N. 2004; Cloning and characterization of a novel mannose-binding protein of Acanthamoeba . J Biol Chem 279:29849–29856 [CrossRef]
    [Google Scholar]
  10. Graff C. L., Pollack G. M. 2005; Nasal drug administration: potential for targeted central nervous system delivery. J Pharm Sci 94:1187–1195 [CrossRef]
    [Google Scholar]
  11. Huber J. D., Egleton R. D., Davis T. P. 2001; Molecular physiology and pathophysiology of tight junctions in the blood-brain barrier. Trends Neurosci 24:719–725 [CrossRef]
    [Google Scholar]
  12. Illum L. 2000; Transport of drugs from the nasal cavity to the central nervous system. Eur J Pharm Sci 11:1–18 [CrossRef]
    [Google Scholar]
  13. Jinga V. V., Gafencu A., Antohe F., Constantinescu E., Heltianu C., Raicu M., Manolescu I., Hunziker W., Simionescu M. 2000; Establishment of a pure vascular endothelial cell line from human placenta. Placenta 21:325–336 [CrossRef]
    [Google Scholar]
  14. Khan N. A. 2001; Pathogenicity, morphology and differentiation of Acanthamoeba . Curr Microbiol 43:391–395 [CrossRef]
    [Google Scholar]
  15. Khan N. A. 2006; Acanthamoeba : biology and increasing importance in human health. FEMS Microbiol Rev 30:564–595 [CrossRef]
    [Google Scholar]
  16. Khan N. A. 2007; Acanthamoeba invasion of the central nervous system. Int J Parasitol 37:131–138 [CrossRef]
    [Google Scholar]
  17. Kim J. H., Kim J. H., Park J. A., Lee S., Kim W. J., Yu Y. S., Kim K. 2006; Blood-neural barrier: intercellular communication at glio-vascular interface. J Biochem Mol Biol 39:339–345 [CrossRef]
    [Google Scholar]
  18. Kong H. H., Kim T. H., Chung D. I. 2000; Purification and characterization of a secretory proteinase of Acanthamoeba healyi isolates from GAE. J Parasitol 86:12–17 [CrossRef]
    [Google Scholar]
  19. Marciano-Cabral F., Cabral G. 2003; Acanthamoeba spp. as agents of disease in humans. Clin Microbiol Rev 16:273–307 [CrossRef]
    [Google Scholar]
  20. Marciano-Cabral F., Puffenbarger R., Cabral G. A. 2000; The increasing importance of Acanthamoeba infections. J Eukaryot Microbiol 47:29–36 [CrossRef]
    [Google Scholar]
  21. Marciano-Cabral F., Ludwick C., Puffenbarger R. A., Cabral G. A. 2004; Differential stimulation of microglial pro-inflammatory cytokines by Acanthamoeba culbertsoni versus Acanthamoeba castellanii . J Eukaryot Microbiol 51:472–479 [CrossRef]
    [Google Scholar]
  22. Martinez A. J. 1985 Free-living Amebas: Natural History, Prevention, Diagnosis, Pathology and Treatment of Disease Boca Raton, FL: CRC Press;
    [Google Scholar]
  23. Martinez A. J. 1991; Infections of the central nervous system due to Acanthamoeba . Rev Infect Dis 13:S399–S402 [CrossRef]
    [Google Scholar]
  24. Martinez A. J., Visvesvara G. S. 1997; Free-living, amphizoic and opportunistic amebas. Brain Pathol 7:583–598 [CrossRef]
    [Google Scholar]
  25. Martinez A. J., Markowitz S. M., Duma R. J. 1975; Experimental pneumonitis and encephalitis caused by Acanthamoeba in mice: pathogenesis and ultrastructural features. J Infect Dis 131:692–699 [CrossRef]
    [Google Scholar]
  26. Mattana A., Cappai V., Alberti L., Serra C., Fiori P. L., Cappuccinelli P. 2002; ADP and other metabolites released from Acanthamoeba castellanii lead to human monocytic cell death through apoptosis and stimulate the secretion of proinflammatory cytokines. Infect Immun 70:4424–4432 [CrossRef]
    [Google Scholar]
  27. Miller D. W. 1999; Immunobiology of the blood-brain barrier. J Neurovirol 5:570–578 [CrossRef]
    [Google Scholar]
  28. Pardridge W. M. 1999; Blood–brain barrier: biology and methodology. J Neurovirol 5:556–569 [CrossRef]
    [Google Scholar]
  29. Pardridge W. M. 2002; Drug and gene delivery to the brain: the vascular route. Neuron 36:555–558 [CrossRef]
    [Google Scholar]
  30. Petry F., Torzewski M., Bohl J., Wilhelm-Schwenkmezger T., Scheid P., Walochnik J., Michel R., Zöller L., Werhahn K. J. other authors 2006; Early diagnosis of Acanthamoeba infection during routine cytological examination of cerebrospinal fluid. J Clin Microbiol 44:1903–1904 [CrossRef]
    [Google Scholar]
  31. Pettit D. A., Williamson J., Cabral G. A., Marciano-Cabral F. 1996; In vitro destruction of nerve cell cultures by Acanthamoeba spp.: a transmission and scanning electron microscopy study. J Parasitol 82:769–777 [CrossRef]
    [Google Scholar]
  32. Shen L., Black E. D., Witkowski E. D., Lencer W. I., Guerriero V., Schneeberger E. E., Turner J. R. 2006; Myosin light chain phosphorylation regulates barrier function by remodeling tight junction structure. J Cell Sci 119:2095–2106 [CrossRef]
    [Google Scholar]
  33. Shin H. J., Cho M. S., Jung S. Y., Kim H. I., Park S., Seo J. H., Yoo J. C., Im K. I. 2001; Cytopathic changes in rat microglial cells induced by pathogenic Acanthamoeba culbertsoni : morphology and cytokine release. Clin Diagn Lab Immunol 8:837–840
    [Google Scholar]
  34. Sissons J., Alsam S., Jayasekera S., Kim K. S., Stins M., Khan N. A. 2004; Acanthamoeba induces cell-cycle arrest in the host cells. J Med Microbiol 53:711–717 [CrossRef]
    [Google Scholar]
  35. Sissons J., Kim K. S., Stins M., Jayasekera S., Alsam S., Khan N. A. 2005; Acanthamoeba castellanii induces host cell death via a phosphatidylinositol 3-kinase-dependent mechanism. Infect Immun 73:2704–2708 [CrossRef]
    [Google Scholar]
  36. Sissons J., Alsam S., Goldsworthy G., Lightfoot M., Jarroll E. L., Khan N. A. 2006; Identification and properties of proteases from an Acanthamoeba isolate capable of producing granulomatous encephalitis. BMC Microbiol 6:42 [CrossRef]
    [Google Scholar]
  37. Stins M. F., Gilles F., Kim K. S. 1997; Selective expression of adhesion molecules on human brain microvascular endothelial cells. J Neuroimmunol 76:81–90 [CrossRef]
    [Google Scholar]
  38. Tuomanen E. 1996; Entry of pathogens into the central nervous system. FEMS Microbiol Rev 18:289–299 [CrossRef]
    [Google Scholar]
  39. Visvesvara G. S., Moura H., Schuster F. L. 2007; Pathogenic and opportunistic free-living amoebae: Acanthamoeba spp., Balamuthia mandrillaris, Naegleria fowleri , and Sappinia diploidea . FEMS Immunol Med Microbiol 50:1–26 [CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.2008/000976-0
Loading
/content/journal/jmm/10.1099/jmm.0.2008/000976-0
Loading

Data & Media loading...

Most cited Most Cited RSS feed